VM5: Regulatory considerations for novel veterinary therapies – Antimicrobials, immunologicals and biologicals
By Raffaele Bruno2025-11-18T10:25:00
Key points:
- Effective emergency response for animal disease outbreaks depends on flexible regulatory pathways: the ability to swiftly deploy vaccines during crises is enabled by legal derogations and coordinated procedures that allow use of non-standard or newly developed vaccines, ensuring rapid disease control and minimising regulatory barriers
- Regulatory readiness for next-generation animal health requires updated frameworks for novel therapies, global harmonisation, digital transformation, real-world data, and agile, collaborative regulatory affairs to foster innovation and effective veterinary product development
To read more key points and the session summary, login as a member or register for free using the links below.